The SARS-CoV-2 virus spreading across the world has led to surges of COVID-19 illness,
hospitalizations, and death. The complex and multifaceted pathophysiology of life …

We conducted a systematic review and a meta-analysis to assess the association of
anticoagulants and their dosage with in-hospital all-cause mortality in COVID-19 patients …

Objective To evaluate whether early initiation of prophylactic anticoagulation compared with
no anticoagulation was associated with decreased risk of death among patients admitted to …

The prognostic role of hypercoagulability in COVID-19 patients is ambiguous. D-dimer, may
be regarded as a global marker of hemostasis activation in COVID-19. Our study was to …

Introduction A hypercoagulable condition was described in patients with coronavirus
disease 2019 (COVID-19) and proposed as a possible pathogenic mechanism contributing …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may induce several
vascular endothelial-dependent systemic complications, and sulodexide has pleiotropic …

Background Venous thromboembolism (VTE) is a frequent complication of COVID-19, so
that the importance of adequate in-hospital thromboprophylaxis in patients hospitalized with …

A single center open label phase 2 randomised control trial (Clinical Trial Registry of India
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …

Despite the emergence of high quality randomized trial data with the use of antithrombotic
agents to reduce the risk of thromboembolism, end‐organ failure, and possibly mortality in …

Background During a pandemic, it is important for clinicians to stratify patients and decide
who receives limited medical resources. Machine learning models have been proposed to …